Vertex finalizes Orkambi deal with Australia

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said it reached an agreement Monday with the Australian government for the reimbursement of cystic fibrosis drug Orkambi lumacaftor/ivacaftor. The country will

Read the full 260 word article

User Sign In